[HTML][HTML] A systematic review to evaluate patient-reported outcome measures (PROMs) for metastatic prostate cancer according to the Consensus-Based Standard for …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - Cancers, 2022 - mdpi.com
Simple Summary Metastatic prostate cancer (mPCa) is one of the most common solid tumors
in men and both the disease and the treatments affect patients' quality of life (QoL). Patient …
in men and both the disease and the treatments affect patients' quality of life (QoL). Patient …
[HTML][HTML] A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - Cancers, 2022 - ncbi.nlm.nih.gov
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the …
M Ratti, G Gandaglia, E Sisca, A Derevianko, E Alleva… - Cancers, 2022 - europepmc.org
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
[PDF][PDF] A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - 2022 - researchgate.net
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
A systematic review to evaluate patient-reported outcomes measures (PROMs) for metastatic prostate cancer according to the consensus-based standard for the …
MM Ratti, G Gandaglia, ES Sisca… - …, 2022 - research.birmingham.ac.uk
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
A Systematic Review to Evaluate Patient-Reported Outcomes Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-based Standard for the …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - …, 2022 - abdn.elsevierpure.com
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measure ment …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measure ment …
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Metastatic prostate cancer (mPCa) is one of the most common
solid tumors in men and both the disease and the treatments affect patients' quality of life …
solid tumors in men and both the disease and the treatments affect patients' quality of life …
[PDF][PDF] A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - 2022 - prostate-pioneer.eu
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the …
MM Ratti, G Gandaglia, ES Sisca, A Derevianko… - …, 2022 - search.proquest.com
Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …
metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement …